The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

The Washington Nationals are close to adding another component to their bullpen, as they are nearing an agreement with right-handed veteran reliever Lucas Sims, as reported byChris Cotillo of ...

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

On Monday, the Diamondbacks officially signed the right-handed reliever, Kendall Graveman. In a corresponding move, righty reliever Seth Martinez was designated for assignment. The 40-man roster ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

To manage the daily pain, frequent brain fog, and sporadic days of full-body exhaustion, my primary care doctor suggested a ...

After the trade, however, he struggled with his new team. In 15 games pitched 14 innings, accruing a 6.43 ERA, 1.500 WHIP, nine strikeouts to 10 walks, and a 68 ERA+. The move did not benefit him ...